Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
Xue‐Ning Shen(Fudan University), Caileigh Zimmerman(University of Southern California), Juliet Fockler, Richard J. Perrin(Washington University in St. Louis), Nina Silverberg(Banner Sun Health Research Institute), Arthur W. Toga(University of California, Los Angeles), Miriam T. Ashford, John Q. Trojanowki(University of Southern California), Andrew J. Saykin(Alzheimer’s Disease Neuroimaging Initiative), Lisa L. Barnes(Rush University Medical Center), María C. Carrillo(Brigham and Women's Hospital), Marie Bernard, Yu Guo(Huashan Hospital), John K. Hsiao(National Institutes of Health), Derek Flenniken(San Francisco VA Medical Center), Shi-Dong Chen(Ningxia Medical University), Laurel Beckett(Brigham and Women's Hospital), Chengshi Jin(University of California, San Francisco), William J. Jagust(Lawrence Berkeley National Laboratory), John C. Morris(Washington University in St. Louis), Hector M. González(University of San Diego), Qiang Dong(Henan Normal University), Eliezer Masliah(University of California San Diego), Cat Conti, Rachel L. Nosheny(University of California, San Francisco), Adrienne Kormos(University of Southern California), Donna Masterman(University of California, Los Angeles), Lan Tan(Qingdao University), Dallas P. Veitch, Leslie M. Shaw(California University of Pennsylvania), Robert C. Green(Boston University), Ozioma C. Okonkwo(University of Wisconsin–Madison), Jin‐Tai Yu(Shanghai Medical College of Fudan University), Yuyuan Huang(Fudan University), Jonathan Jackson(National Institutes of Health), Laurie Ryan(Alzheimer's Association), Michael W. Weiner(San Francisco VA Medical Center), Carole Ho, Paul Aisen(WinnMed), Devon Gessert(UC San Diego Health System), William C. Potter(Eli Lilly (United States)), Ronald Petersen(Mayo Clinic), Jennifer Salazar, Clifford R. Jack(Mayo Clinic), Gustavo Jiménez, John Neuhaus(Max Planck Research Unit for Neurogenetics)
Cited by 70
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k